Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Syngene International IPO is a book built issue of Rs 550.00 crores.
Syngene International IPO bidding started from July 27, 2015 and ended on July 29, 2015. The shares got listed on BSE, NSE on August 11, 2015.
Syngene International IPO price band is set at ₹240 to ₹250 per share. The minimum lot size for an application is 60 Shares. The minimum amount of investment required by retail investors is ₹15,000.
Axis Bank Limited, Credit Suisse Securities (India) Private Limited and Jefferies India Private Limited are the book running lead managers of the Syngene International IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Syngene International IPO RHP for detailed information.
| IPO Date | July 27, 2015 to July 29, 2015 |
| Listing Date | August 11, 2015 |
| Face Value | ₹10 per share |
| Price Band | ₹240 to ₹250 per share |
| Lot Size | 60 Shares |
| Total Issue Size | 22,000,000 shares (aggregating up to ₹550.00 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
Syngene International IPO offers 16,000,000 shares. 4,000,000 (25.00%) to QIB, 3,000,000 (18.75%) to NII, 7,000,000 (43.75%) to RII. 116,666 RIIs will receive minimum 60 shares and (sNII) and (bNII) will receive minimum 840 shares. (in case of oversubscription)
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | - | NA |
| QIB Shares Offered | 4,000,000 (25.00%) | NA |
| NII (HNI) Shares Offered | 3,000,000 (18.75%) | |
| Retail Shares Offered | 7,000,000 (43.75%) | 116,666 | Other Shares Offered | 2,000,000 (12.50%) | NA |
| Total Shares Offered | 16,000,000 (100%) |
Investors can bid for a minimum of 60 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 60 | ₹15,000 |
| Retail (Max) | 13 | 780 | ₹195,000 |
| Lot Size Calculator | |||
Incorporated in 1993, Syngene International Ltd is a subsidiary of Biocon Limited ("Biocon"), a global biopharmaceutical enterprise focused on delivering affordable formulations and compounds.
Headquartered in Bengaluru, Syngene International is India-based contract research organisations ("CRO"), offering a suite of integrated, end-to-end discovery and development services for novel molecular entities ("NMEs") across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. Their services in discovery and development cover multiple domains across small molecules, large molecules, antibody-drug conjugates ("ADC") and oligonucleotides.
Syngene offer customized models as per their clients requirements. These range from a full-time equivalent ("FTE") to a fee-for-service ("FFS") model, or a combination thereof. Till Dec 31, 2014, they serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014. Company's long term clients includes global healthcare organisations Bristol-Myers Squibb Co. ("BMS"), Abbott Laboratories (Singapore) Pte. Ltd. ("Abbott") and Baxter International Inc. ("Baxter").
| Particulars | For the year/period ended (in Rs. Million) | |||
| 31 Dec 14 | 31 Mar 14 | 31 Mar 13 | 31 Mar 12 | |
| Total Income | 6,175 | 7,077 | 5,542 | 4,182 |
| Profit After Tax (PAT) | 1,194 | 1,348 | 1,021 | 710 |
The objects of the offer are to:
1. Achieve the benefits of listing the Equity Shares on the Stock Exchanges;
2. Enhance visibility and brand image among existing and potential clients; and
3. Provide liquidity to the existing shareholders.
[Dilip Davda]
Syngene Intl Ltd - Modest investment recommended
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published here. Any reader taking decisions based on any information published here does so entirely at own risk. Author has no plans to invest in this offer.
Read detail review...The Syngene International IPO is subscribed 32.05 times on July 29, 2015 6:10:00 PM. The public issue subscribed 4.78 times in the retail category, 51.47 times in the QIB category, and 90.24 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 51.47 |
| NII | 90.24 |
| Retail | 4.78 |
| Others | 1.37 |
| Total | 32.05 |
| Listing Date | August 11, 2015 |
| BSE Script Code | 539268 |
| NSE Symbol | SYNGENE |
| ISIN | INE398R01022 |
| Final Issue Price | ₹250 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹250.00 |
| ₹295.00 |
| ₹295.00 |
| ₹318.20 |
| ₹310.40 |
| NSE |
|---|
| ₹250.00 |
| ₹295.00 |
| ₹295.00 |
| ₹318.50 |
| ₹310.55 |
Syngene International Ltd
Biocon SEZ Biocon Park,
Plot No 2 & 3 Bommasandra Inds,
Bengaluru - 560099, Karnataka
Phone: +91-80-28082808
Email: investor@syngeneintl.com
Website: http://www.syngeneintl.com
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: einward.ris@karvy.com
Website: https://kosmic.kfintech.com/ipostatus/
Syngene International IPO is a main-board IPO of 22,000,000 equity shares of the face value of ₹10 aggregating up to ₹550.00 Crores. The issue is priced at ₹240 to ₹250 per share. The minimum order quantity is 60 Shares.
The IPO opens on July 27, 2015, and closes on July 29, 2015.
Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Syngene International IPO opens on July 27, 2015 and closes on July 29, 2015.
Syngene International IPO lot size is 60 Shares, and the minimum amount required is ₹15,000.
You can apply in Syngene International IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Syngene International IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Syngene International IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Guru (2600+ Posts, 2700+ Likes)
GIRISH KULKARNI| Link | Bookmark |September 24, 2015 1:44:08 PM